785 related articles for article (PubMed ID: 30100720)
1. Reduction-sensitive CD44 receptor-targeted hyaluronic acid derivative micelles for doxorubicin delivery.
Yang Y; Zhao Y; Lan J; Kang Y; Zhang T; Ding Y; Zhang X; Lu L
Int J Nanomedicine; 2018; 13():4361-4378. PubMed ID: 30100720
[TBL] [Abstract][Full Text] [Related]
2. Free Adriamycin-Loaded pH/Reduction Dual-Responsive Hyaluronic Acid-Adriamycin Prodrug Micelles for Efficient Cancer Therapy.
Yin T; Wang Y; Chu X; Fu Y; Wang L; Zhou J; Tang X; Liu J; Huo M
ACS Appl Mater Interfaces; 2018 Oct; 10(42):35693-35704. PubMed ID: 30259743
[TBL] [Abstract][Full Text] [Related]
3. Redox-sensitive and hyaluronic acid functionalized liposomes for cytoplasmic drug delivery to osteosarcoma in animal models.
Chi Y; Yin X; Sun K; Feng S; Liu J; Chen D; Guo C; Wu Z
J Control Release; 2017 Sep; 261():113-125. PubMed ID: 28666726
[TBL] [Abstract][Full Text] [Related]
4. CD44-specific nanoparticles for redox-triggered reactive oxygen species production and doxorubicin release.
Lin CW; Lu KY; Wang SY; Sung HW; Mi FL
Acta Biomater; 2016 Apr; 35():280-92. PubMed ID: 26853764
[TBL] [Abstract][Full Text] [Related]
5. Self-assembled pH-responsive hyaluronic acid-g-poly((L)-histidine) copolymer micelles for targeted intracellular delivery of doxorubicin.
Qiu L; Li Z; Qiao M; Long M; Wang M; Zhang X; Tian C; Chen D
Acta Biomater; 2014 May; 10(5):2024-35. PubMed ID: 24365705
[TBL] [Abstract][Full Text] [Related]
6. pH- and GSH-Sensitive Hyaluronic Acid-MP Conjugate Micelles for Intracellular Delivery of Doxorubicin to Colon Cancer Cells and Cancer Stem Cells.
Debele TA; Yu LY; Yang CS; Shen YA; Lo CL
Biomacromolecules; 2018 Sep; 19(9):3725-3737. PubMed ID: 30044910
[TBL] [Abstract][Full Text] [Related]
7. GE11 peptide modified and reduction-responsive hyaluronic acid-based nanoparticles induced higher efficacy of doxorubicin for breast carcinoma therapy.
Hu D; Mezghrani O; Zhang L; Chen Y; Ke X; Ci T
Int J Nanomedicine; 2016; 11():5125-5147. PubMed ID: 27785019
[TBL] [Abstract][Full Text] [Related]
8. Hyaluronic acid-decorated redox-sensitive chitosan micelles for tumor-specific intracellular delivery of gambogic acid.
Xu W; Wang H; Dong L; Zhang P; Mu Y; Cui X; Zhou J; Huo M; Yin T
Int J Nanomedicine; 2019; 14():4649-4666. PubMed ID: 31303753
[No Abstract] [Full Text] [Related]
9. The effect of dual-functional hyaluronic acid-vitamin E succinate micelles on targeting delivery of doxorubicin.
Wang J; Ma W; Guo Q; Li Y; Hu Z; Zhu Z; Wang X; Zhao Y; Chai X; Tu P
Int J Nanomedicine; 2016; 11():5851-5870. PubMed ID: 27853369
[TBL] [Abstract][Full Text] [Related]
10. Dual targeting folate-conjugated hyaluronic acid polymeric micelles for paclitaxel delivery.
Liu Y; Sun J; Cao W; Yang J; Lian H; Li X; Sun Y; Wang Y; Wang S; He Z
Int J Pharm; 2011 Dec; 421(1):160-9. PubMed ID: 21945183
[TBL] [Abstract][Full Text] [Related]
11. pH-Responsive Hyaluronic Acid-Based Mixed Micelles for the Hepatoma-Targeting Delivery of Doxorubicin.
Wu JL; Tian GX; Yu WJ; Jia GT; Sun TY; Gao ZQ
Int J Mol Sci; 2016 Mar; 17(4):364. PubMed ID: 27043540
[TBL] [Abstract][Full Text] [Related]
12. Reduction sensitive hyaluronan-SS-poly(ε-caprolactone) block copolymers as theranostic nanocarriers for tumor diagnosis and treatment.
Yang H; Wang N; Mo L; Wu M; Yang R; Xu X; Huang Y; Lin J; Zhang LM; Jiang X
Mater Sci Eng C Mater Biol Appl; 2019 May; 98():9-18. PubMed ID: 30813097
[TBL] [Abstract][Full Text] [Related]
13. Zwitterionic pH-responsive hyaluronic acid polymer micelles for delivery of doxorubicin.
Gao QQ; Zhang CM; Zhang EX; Chen HY; Zhen YH; Zhang SB; Zhang SF
Colloids Surf B Biointerfaces; 2019 Jun; 178():412-420. PubMed ID: 30903980
[TBL] [Abstract][Full Text] [Related]
14. Tumor microenvironment dual-responsive core-shell nanoparticles with hyaluronic acid-shield for efficient co-delivery of doxorubicin and plasmid DNA.
Wang T; Yu X; Han L; Liu T; Liu Y; Zhang N
Int J Nanomedicine; 2017; 12():4773-4788. PubMed ID: 28740384
[TBL] [Abstract][Full Text] [Related]
15. Targeted delivery of Doxorubicin by folic acid-decorated dual functional nanocarrier.
Lu J; Zhao W; Huang Y; Liu H; Marquez R; Gibbs RB; Li J; Venkataramanan R; Xu L; Li S; Li S
Mol Pharm; 2014 Nov; 11(11):4164-78. PubMed ID: 25265550
[TBL] [Abstract][Full Text] [Related]
16. Facile strategy by hyaluronic acid functional carbon dot-doxorubicin nanoparticles for CD44 targeted drug delivery and enhanced breast cancer therapy.
Li J; Li M; Tian L; Qiu Y; Yu Q; Wang X; Guo R; He Q
Int J Pharm; 2020 Mar; 578():119122. PubMed ID: 32035259
[TBL] [Abstract][Full Text] [Related]
17. 1, 2-Dihexadecanoyl-sn-glycero-3-phosphoethanolamin (DPPE), doxorubicin and folic acid conjugated micelles for cancer management in tumor bearing BALB/c mice.
Uttekar PS; Yadav VD; Bhagwat DA
Bioorg Med Chem Lett; 2021 Oct; 50():128337. PubMed ID: 34438013
[TBL] [Abstract][Full Text] [Related]
18. Comparison of hyaluronic acid-based micelles and polyethylene glycol-based micelles on reversal of multidrug resistance and enhanced anticancer efficacy in vitro and in vivo.
Wang J; Li Y; Wang L; Wang X; Tu P
Drug Deliv; 2018 Nov; 25(1):330-340. PubMed ID: 29350064
[TBL] [Abstract][Full Text] [Related]
19. Dual CD44 and folate receptor-targeted nanoparticles for cancer diagnosis and anticancer drug delivery.
Lee JY; Termsarasab U; Park JH; Lee SY; Ko SH; Shim JS; Chung SJ; Cho HJ; Kim DD
J Control Release; 2016 Aug; 236():38-46. PubMed ID: 27320169
[TBL] [Abstract][Full Text] [Related]
20. Multifunctional mesoporous silica nanoparticles modified with tumor-shedable hyaluronic acid as carriers for doxorubicin.
Zhang J; Sun Y; Tian B; Li K; Wang L; Liang Y; Han J
Colloids Surf B Biointerfaces; 2016 Aug; 144():293-302. PubMed ID: 27107383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]